Teva Pharmaceutical Industries (TEVA) Receivables - Other (2014 - 2015)
Teva Pharmaceutical Industries' (TEVA) quarterly Receivables - Other came in at $125.0 million in Q1 2015, little changed quarter-over-quarter from $125.0 million in Q4 2014.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Receivables - Other (2014 - 2015) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has reported Receivables - Other for 2 consecutive years, with $125.0 million the latest figure, recorded in Q1 2015.
- For the quarter ending Q1 2015, Receivables - Other changed N/A year-over-year to $125.0 million; the trailing twelve-month figure through Mar 2015 stood at $125.0 million (changed N/A YoY), and the FY2014 full-year result was $125.0 million, changed N/A from the prior year.
- Receivables - Other held at $125.0 million in Q1 2015 per TEVA's latest filing, from $125.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $125.0 million in Q3 2014 and bottomed at $125.0 million in Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2015 | 125.00 Mn |
| Dec 31, 2014 | 125.00 Mn |
| Sep 30, 2014 | 125.00 Mn |